We are live on ! Find out more
ACM

Ayer Capital Management Portfolio holdings

AUM $26.8M
This Fund
S&P 500
This Quarter Est. Return
-18.92%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$26.8M
AUM Growth
-$41.4M
Cap. Flow
-$31M
Cap. Flow %
-115.7%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$31M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
1
Iovance Biotherapeutics
IOVA
$1.82B
$25.9M 96.51%
2,823,333
-2,780,682
-50% -$31M
CASC
2
DELISTED
Cascadian Therapeutics, Inc.
CASC
$935K 3.49%
41,667

Similar funds

Ayer Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Ayer Capital Management held 2 positions worth $26.8M, down 61% from $68.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Ayer Capital Management withdrew a net $31M in Q2 2015, reducing 1 holding. Its largest reduction was Iovance Biotherapeutics, cutting an estimated $31M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ayer Capital Management's biggest Q2 2015 reduction was Iovance Biotherapeutics, cutting an estimated $31M.
  • Ayer Capital Management's ten largest holdings make up 100% of its $26.8M portfolio in Q2 2015.
  • Ayer Capital Management opened 0 new positions and closed 0 in Q2 2015.
  • Ayer Capital Management's portfolio value fell 61% quarter-over-quarter to $26.8M.

Based on Ayer Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.